Pushing through on a plan to get out of the early-stage anti-infectives R&D space, AstraZeneca ($AZN) is spinning out its Waltham, MA-based company into an ...

WALTHAM - British drug maker AstraZeneca PLC on Monday announced a $100 million expansion of its facility here to boost research and development of drugs that treat cancer and infectious diseases.

Last summer, AstraZeneca ($AZN) formally spun out its pared-down early-stage antibiotics unit in Waltham, MA, as Entasis Therapeutics, bequeathing a $40 million A ...

Entasis Therapeutics, an antibiotics developer that spun out of AstraZeneca plc in 2015, has been acquired by its majority shareholder, California's Innoviva Inc. The battle against bugs ...

Vanguard Renewables has signed a contract with drug giant AstraZeneca to deliver renewable natural gas to all of AstraZeneca’s 12 sites in the United States. Waltham-based Vanguard is developing ...

Waltham-based AstraZeneca advance its TB drug developed in Waltham. UK-based drug giant AstraZeneca plc (NYSE: AZN) announced it has launched a Phase 2 clinical trial in South Africa with its ...

Entasis is one of eight start-up labs in the new Waltham Bio-Hub. The Hub, supported by pharmaceutical giant AstraZeneca, was created to foster the next generation of medical breakthroughs.

Entasis is one of eight start-up labs in the new Waltham Bio-Hub. The Hub, supported by pharmaceutical giant AstraZeneca, was created to foster the next generation of medical breakthroughs.On a ...

X-Chem Inc., a Waltham-based biotechnology company focused on developing small molecule drugs, said Thursday that it is expanding its collaboration with AstraZeneca PLC, a large Anglo-Swedish drug ...

LONDON (AP) — The board of pharmaceutical company AstraZeneca on Friday flatly rejected drug maker Pfizer’s sweetened takeover offer just hours after it was levelled, describing it as inadequate.